Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Demographic and clinical characteristics and risk factors for Staphylococcal scalded skin syndrome in Hunan.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences·2016
Same author

Study on enhanced degradation of atrazine by ozonation in the presence of hydroxylamine.

Journal of hazardous materials·2016
Same author

A contrastive analysis of laser heating between the human and guinea pig cochlea by numerical simulations.

Biomedical engineering online·2016
Same author

Moxibustion upregulates hippocampal progranulin expression.

Neural regeneration research·2016
Same author

Transcriptional Profiles of Drought-Related Genes in Modulating Metabolic Processes and Antioxidant Defenses in Lolium multiflorum.

Frontiers in plant science·2016
Same author

Inhibitory effects of geraniin on LPS-induced inflammation via regulating NF-κB and Nrf2 pathways in RAW 264.7 cells.

Chemico-biological interactions·2016
Same journal

Research on Predicting the Efficacy of Immunotherapy for Non-small Cell Lung Cancer Based on CT Radiomics and Peripheral Blood Inflammatory Markers.

Technology in cancer research & treatment·2026
Same journal

Survival Prediction in Patients With Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer With Bone Metastases Receiving Icotinib Therapy: A Retrospective Observational Study.

Technology in cancer research & treatment·2026
Same journal

Proteomics in Acute Myeloid Leukemia: Current Applications in Precision Medicine and Targeted Immunotherapy.

Technology in cancer research & treatment·2026
Same journal

EML4-ALK in Non-small Cell Lung Cancer: Molecular Mechanisms and Targeted Therapies.

Technology in cancer research & treatment·2026
Same journal

Developing and Validating a Risk Model for Severe Bone Marrow Suppression in Esophageal Cancer Treated with Radiotherapy or Chemoradiotherapy: A Retrospective Cohort Study.

Technology in cancer research & treatment·2026
Same journal

A Novel Adjustable Tandem and Ring Applicator for Improved Dosimetry in Cervical Cancer HDR Brachytherapy.

Technology in cancer research & treatment·2026
See all related articles

Related Experiment Video

Updated: Dec 15, 2025

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

1.3K

CFIm25 in Solid Tumors: Current Research Progress.

Xiaojie Sun1, Ji Li2, Xun Sun3

  • 1Department of Gastroenterology, the First Hospital of Jilin University, Changchun, Jilin, China.

Technology in Cancer Research & Treatment
|July 10, 2020
PubMed
Summary
This summary is machine-generated.

Cleavage factor I m25, a gene linked to solid tumors, influences RNA processing and can inhibit or promote cancer. Further research is needed to understand its complex role in cancer pathogenesis and treatment.

Keywords:
alternative polyadenylationcleavage factor I m25genetumor

More Related Videos

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
07:52

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts

Published on: April 26, 2018

9.3K
Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

900

Related Experiment Videos

Last Updated: Dec 15, 2025

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

1.3K
Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
07:52

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts

Published on: April 26, 2018

9.3K
Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

900

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Cleavage factor I m25 is a newly identified gene associated with solid tumors.
  • Its exact role in cancer development remains largely uncharacterized.
  • Alternative polyadenylation (APA) is a crucial RNA processing mechanism generating distinct mRNA isoforms.

Purpose of the Study:

  • To review the role of Cleavage factor I m25 (CFIm25) in solid tumors.
  • To explore the implications of CFIm25 in cancer pathogenesis and therapeutic strategies.
  • To highlight the necessity for further investigation into CFIm25 and APA mechanisms in disease.

Main Methods:

  • Literature review focusing on studies related to Cleavage factor I m25 and alternative polyadenylation in solid tumors.
  • Analysis of existing research on the function of CFIm25 in mRNA maturation and cell signaling.
  • Synthesis of information regarding CFIm25's dual role as a tumor suppressor and oncogene.

Main Results:

  • Cleavage factor I m25 is integral to mRNA maturation and cell signal transduction via alternative polyadenylation.
  • Regulation of APA by CFIm25 can suppress tumor proliferation, invasion, and metastasis in various cancers.
  • CFIm25 exhibits context-dependent activity, functioning as an oncogene in certain tumor types.

Conclusions:

  • Cleavage factor I m25 plays a significant, albeit complex, role in the development and progression of solid tumors.
  • Understanding the regulatory mechanisms of CFIm25 and APA is critical for developing novel cancer treatments.
  • Further research is essential to fully elucidate the multifaceted functions of CFIm25 in both cancer and other diseases.